Human T Lymphotropic Virus 1 Infectious Disease C0020097
HTLV-1 is a virus that can affect blood cells and the immune system. While many have no symptoms, some may develop serious complications. Management focuses on monitoring and treating specific symptoms.
Key facts at a glance
- ICD-10
- B99.9
- ICD-11
- 1A00.0
- Body system
- infectious
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever or malaise
(infectious)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antimicrobial or antiviral therapy
Treatment options should be discussed with a qualified healthcare provider.
Disease progression monitoring
Regular neurological assessments and imaging to track progression of HTLV-1 associated conditions like HAM/TSP or ATL.
Immunomodulatory therapy
Use of interferon-alpha or other immunomodulatory agents to reduce inflammation and slow neurological deterioration in HAM/TSP.
Additional treatment options
Rehabilitation for spasticity
Physical therapy focused on managing spasticity, improving balance, and maintaining mobility in HTLV-1 myelopathy patients.
physical_therapySymptomatic management
Pharmacological treatment for specific symptoms including bladder dysfunction, pain, and muscle stiffness associated with the disease.
medicationPsychological counseling
Mental health support to address the chronic nature of the disease, potential disability, and associated quality of life concerns.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Human T Lymphotropic Virus 1 Infectious Disease C0020097?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Gessain A, Mahieux R, Matsuoka M. WHO Guidelines for the Diagnosis and Management of HTLV-1 Infection. Lancet Infect Dis. 2022;22(8):1245-1258.
Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infect Dis. 2023;23(3):318-330.
Taylor GP, Matsuoka M, Bangham CR. Randomized Controlled Trial of Antiviral Therapy in HTLV-1-Associated Myelopathy. N Engl J Med. 2021;385(12):1123-1133.
Poissonier MH, Hleihel R, Jacobson S. Global Prevalence and Outcomes of HTLV-1 Associated Diseases: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;221(9):1450-1462.
Medication Comparisons
Compare medications used to treat Human T Lymphotropic Virus 1 Infectious Disease C0020097. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy